GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE283nnn/GSE283388/primaryOK200TranscriptomicsHomo sapiensExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283388GEOGSEfalseGene Expression Profiling in Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines Treated with SelinexorThis study focuses on the transcriptional response of diffuse large B-cell lymphoma (DLBCL) cell lines, SU-DHL6 and OCI-LY3, to Selinexor treatment. Selinexor, a selective inhibitor of nuclear export (SINE), is known for its antitumor properties. RNA-sequencing was performed to investigate gene expression changes in these DLBCL models after 24 and 48 hours of treatment. The goal is to uncover key molecular pathways and targets influenced by Selinexor, providing insights into its therapeutic potential in DLBCL.2026/05/12GSE283388GSM8661279GSM8661278GSM8661277GSM8661283GSM8661282GSM8661281GSM8661280GSM8661287GSM8661276GSM8661286GSM8661285GSM866128424676283388Homo sapiens[41857699]